CNTB
Connect Biopharma Holdings Limited
$1.71
+$0.16(+10.32%)
51
Overall
--
Value
80
Tech
23
Quality
Market Cap
$85.81M
Volume
94.82K
52W Range
$0.51 - $2.86
Target Price
$6.83
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec |
|---|---|---|---|---|
| COST OF GOODS SOLD | ||||
| Cost of Revenue | $-8.0M | -- | ||
| GROSS PROFIT | ||||
| Gross Profit | $8.0M | -- | ||
| OPERATING EXPENSES | ||||
| Operating Expenses | $101.2M | $66.4M | ||
| Research & Development | $93.6M | $527.0K | ||
| Research Expense | $93.6M | $527.0K | ||
| Selling, General & Administrative | $20.0M | $8.9M | ||
| General & Administrative Expenses | $20.0M | $8.9M | ||
| Salaries & Wages | $-143.8M | $15.4M | ||
| Depreciation & Amortization | $-6.9M | $988.0K | ||
| Depreciation & Amortization | $-6.9M | $988.0K | ||
| Amortization | $-60.0K | -- | ||
| Other Operating Expenses | $-12.4M | $40.6M | ||
| OPERATING INCOME | ||||
| Operating income | $-101.2M | $-66.4M | ||
| EBITDA | $-802.1M | $-58.4M | ||
| NON-OPERATING ITEMS | ||||
| Interest Expense (Non-Operating) | $-144.0K | $23.0K | ||
| Intinc | $10.7M | $2.7M | ||
| Net Non-Operating Interest Income/Expense | $10.7M | $2.6M | ||
| Gain on Sale of Securities | $1.7M | $2.5M | ||
| Other Income/Expense | $-924.0K | $-4.1M | ||
| Other Special Charges | $924.0K | $1.6M | ||
| SPECIAL ITEMS | ||||
| Special Income Charges | $-32.8M | -- | ||
| Impairment of Capital Assets | $32.8M | -- | ||
| PRE-TAX INCOME | ||||
| EBIT | $-795.2M | $-59.4M | ||
| Pre-Tax Income | $-795.0M | $-59.4M | ||
| INCOME TAX | ||||
| Tax Provision | $2.0M | $120.0K | ||
| NET INCOME | ||||
| Net Income | $-124.5M | $-59.5M | ||
| Net Income (Continuing Operations) | $-124.5M | $-59.5M | ||
| Net Income (Discontinued Operations) | $-124.5M | $-59.5M | ||
| Net Income (Common Stockholders) | $-124.5M | $-59.5M | ||
| Normalized Income | -- | $-43.6M | ||
| TOTALS | ||||
| Total Expenses | $93.2M | $66.4M | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $55.0M | $55.1M | ||
| Average Shares Outstanding (Diluted) | $59.3M | $55.1M | ||
| Shares Outstanding | $55.0M | $55.7M | ||
| Basic EPS | $-14.5 | $-1.08 | ||
| Basic EPS (Continuing Operations) | -- | $-1.08 | ||
| Diluted EPS | $-2.1 | $-1.08 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.08 | ||
| OTHER METRICS | ||||
| Gain On Sale Of P P E | $-4.0K | -- | ||
| Loss And Loss Adjustment Expected Incurred | $144.0K | -- | ||
| Other Gand A | $20.0M | $8.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CNTB | $1.71 | +10.3% | 94.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Connect Biopharma Holdings Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW